Oct-Dec Earnings
Sun Pharma consol PAT up YoY at INR 33.69 bln, beats estimates
This story was originally published at 14:50 IST on 31 January 2026
Register to read our real-time news..jpeg&w=1920&q=75 "Oct-Dec-Earnings-Sun-Pharma-consol-PAT-up-YoY-at-INR-33-69-bln-beats-estimates")
Informist, Saturday, Jan. 31, 2026
MUMBAI – Sun Pharmaceutical Industries Ltd.'s consolidated net profit for the quarter ended December was INR 33.69 billion, higher than INR 29.03 billion a year ago. Analysts had pegged the net profit for the period at INR 29.81 billion. The company's consolidated revenue for the quarter was INR 155.21 billion, higher than INR 136.75 billion ago a year ago. This was also higher than analysts' estimate of INR 147.66 billion. The company declared an interim dividend of INR 11 per share.
* Sun Pharma Oct-Dec consol net profit INR 33.69 bln
* Analysts saw Sun Pharma Oct-Dec consol net profit at INR 29.81 bln
* Sun Pharma Oct-Dec consol revenue INR 155.21 bln
* Analysts saw Sun Pharma Oct-Dec consol revenue at INR 147.66 bln
* Sun Pharma Oct-Dec consol net profit INR 33.69 bln vs INR 29.03 bln yr ago
* Sun Pharma Oct-Dec consol revenue INR 155.21 bln vs INR 136.75 bln yr ago
* Sun Pharma to pay INR 11 per share interim dividend
* Sun Pharma interim dividend record date is Feb 5
* Sun Pharma Oct-Dec net profit includes one-time cost INR 4.89 bln
* Sun Pharma Q3 net profit includes one-time tax write back of INR 3.22 bln
* Sun Pharma Oct-Dec profit excluding one-time cost, tax credit INR 35.37 bln
* Sun Pharma Apr-Dec consol net profit INR 87.65 bln vs INR 87.79 bln yr ago
* Sun Pharma Apr-Dec consol revenue INR 438.50 bln vs INR 396.20 bln yr ago
To read more please subscribe
Share this Story:
